Advisor Group’s T2 Biosystems, Inc TTOO Stock Holding History

Advisor Group’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$8K	Sell	1 -2	-67%	-$18.9K	﹤0.01%	4478
2019 Q3	$41K	Buy	3 +1	+50%	+$8.03K	﹤0.01%	3535
2019 Q2	$20K	Buy	2 +1	+100%	+$11.7K	﹤0.01%	3990
2019 Q1	$15K	Hold	1	–	–	﹤0.01%	4160
2018 Q4	$21K	Hold	1	–	–	﹤0.01%	3785
2018 Q3	$38K	Buy	+1	New	+$32.9K	﹤0.01%	3486
2018 Q2	–	Hold	0	–	–	–	4493
2018 Q1	–	Hold	0	–	–	–	4611
2017 Q4	–	Hold	0	–	–	–	4598
2017 Q3	–	Hold	0	–	–	–	4744
2017 Q2	–	Hold	0	–	–	–	4707
2017 Q1	–	Hold	0	–	–	–	4605
2016 Q4	–	Hold	0	–	–	–	4420
2016 Q3	–	Hold	0	–	–	–	4374
2016 Q2	–	Hold	0	–	–	–	4530

Other funds holding TTOO

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Advisor Group's TTOO Position: Q4 2019 in Review

Advisor Group reduced its T2 Biosystems, Inc (TTOO) stake by 67% in Q4 2019, selling an estimated $18.9K and leaving 1 share worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #4478.

Advisor Group first reported a position in TTOO in Q3 2018 and has held it in 6 quarters since. The position peaked at $41K in Q3 2019. 43 funds tracked by Wall St. Rank hold TTOO as of Q4 2019.

Advisor Group held 1 share of T2 Biosystems, Inc worth $8K as of Q4 2019.
Advisor Group sold 2 T2 Biosystems, Inc shares in Q4 2019, an estimated $18.9K.
T2 Biosystems, Inc made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4478 holding.
Advisor Group first reported a position in T2 Biosystems, Inc in Q3 2018 and has held it in 6 quarters since.
Advisor Group's T2 Biosystems, Inc position peaked at $41K in Q3 2019.
43 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.